Asena Keleş Şahin1, Ahmet Şahap Kükner2, Fatih Ulaş2, Ümit Doğan2. 1. Department of Ophthalmology, Training and Research Hospital, Ordu University, Ordu 52000, Turkey. 2. Department of Ophthalmology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu 14280, Turkey.
Abstract
AIM: To evaluate the effect of topical preoperative nepafenac 0.1% treatment on postoperative macular edema using optical coherence tomography (OCT) after uncomplicated cataract surgery. METHODS:Ninety eyes of 90 patients without any risk factors were included in the study. The patients were assigned to three groups: group 1, treated with topical prednisolone acetate 1%; group 2, treated with topical nepafenac 0.1% in addition to prednisolone acetate (1%); and group 3, those who started receiving nepafenac 0.1% treatment 3d prior to surgery and continued the treatment postoperatively in addition to prednisolone acetate (1%). Central retinal thickness (CRT) and macular volume values were recorded using OCT at weeks 3 and 6. RESULTS: The increases in macular volume in the central 1 mm area after 3 and 6wk were significantly lower in patients who used prophylactic topical nepafenac preoperatively (group 3) compared with those in group 1 (P=0.028 and 0.008, respectively). No significant differences in the increase in macular volume and CRT were noted between groups 2 and 3 (P>0.05). In group 1, the increases in macular volume in the central 3 mm area at weeks 3 and 6 were significantly higher than that in group 2 and 3 (3rd week, P=0.004; 6th week, P=0.005). CONCLUSION:Nepafenac 0.1% treatment in addition to topical steroids after uncomplicated cataract surgery reduce the increase in macular volume in the early postoperative period. International Journal of Ophthalmology Press.
RCT Entities:
AIM: To evaluate the effect of topical preoperative nepafenac 0.1% treatment on postoperative macular edema using optical coherence tomography (OCT) after uncomplicated cataract surgery. METHODS: Ninety eyes of 90 patients without any risk factors were included in the study. The patients were assigned to three groups: group 1, treated with topical prednisolone acetate 1%; group 2, treated with topical nepafenac 0.1% in addition to prednisolone acetate (1%); and group 3, those who started receiving nepafenac 0.1% treatment 3d prior to surgery and continued the treatment postoperatively in addition to prednisolone acetate (1%). Central retinal thickness (CRT) and macular volume values were recorded using OCT at weeks 3 and 6. RESULTS: The increases in macular volume in the central 1 mm area after 3 and 6wk were significantly lower in patients who used prophylactic topical nepafenac preoperatively (group 3) compared with those in group 1 (P=0.028 and 0.008, respectively). No significant differences in the increase in macular volume and CRT were noted between groups 2 and 3 (P>0.05). In group 1, the increases in macular volume in the central 3 mm area at weeks 3 and 6 were significantly higher than that in group 2 and 3 (3rd week, P=0.004; 6th week, P=0.005). CONCLUSION:Nepafenac 0.1% treatment in addition to topical steroids after uncomplicated cataract surgery reduce the increase in macular volume in the early postoperative period. International Journal of Ophthalmology Press.
Authors: Friederike Schaub; Werner Adler; Philip Enders; Meike C Koenig; Konrad R Koch; Claus Cursiefen; Bernd Kirchhof; Ludwig M Heindl Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-03-21 Impact factor: 3.117
Authors: José Maurício Botto de Barros Garcia; David Leonardo Cruvinel Isaac; Marcos Pereira de Ávila Journal: Arq Bras Oftalmol Date: 2016-04 Impact factor: 0.872
Authors: Rishi Singh; Louis Alpern; Glenn J Jaffe; Robert P Lehmann; John Lim; Harvey J Reiser; Kenneth Sall; Thomas Walters; Dana Sager Journal: Clin Ophthalmol Date: 2012-08-03